baber/WOPTO huggingface dataset:
Patent JP-2622951-B2 (JP)
IPC: H04N3/237
Filed: 1985-11-27
Granted: 1997-06-25
Abstract: Vertical beam landing errors in color cathode ray tubes are corrected by a digital delay circuit (20) which provides horizontal scan line video pixel information at its proper location to produce a distortion corrected raster. Accurate correction is provided by sample interpolation techniques (31, 32, 37) that effectively form derived pixels that have an apparent location between scan-lines that corrects the scanning distortions. The location of the derived pixel relative to the video pixel samples can be determined by the selection (34, 35) of the interpolating coefficients. Such correction is preferably combined with a scan line offset technique (34, 30) providing a coarse correction.
Patent JP-H0667827-B2 (JP)
IPC: A61Q19/08
Filed: 1986-11-14
Abstract: The present invention relates to compositions and methods for inhibiting protein aging. Accordingly, a composition is disclosed which comprises an agent or compound capable of inhibiting the formation of advanced glycosylation end products of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. Suitable agents may contain an active nitrogen-containing group, such as a hydrazine group, and may further be at least partially derived from amino acids. Particular agents comprise aminoguanidine,  alpha -hydrazinohistidine and lysine. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.
Patent JP-H0737978-B2 (JP)
IPC: G01N33/49
Filed: 1987-10-30
Abstract: Methods for reproducibly labelling viable cells with cyanine dyes that do not significantly affect cell viability. Applications for labelled cells include using labelled red blood cells to distinguish post-transfusional bleeding from immunologic reaction and using dilution to measure growth rate of cultured cells.
Patent JP-H0786190-B2 (JP)
IPC: C09J7/02
Filed: 1986-12-10
Abstract: Permanently tacky pressure sensitive adhesives comprise terpolymers consisting essentially of 35-50% by weight of a vinyl ester of an alkanoic acid, 15-30% by weight ethylene and 35-50% by weight of di-2-ethylhexyl maleate or di-n-octyl maleate or di-n-octyl maleate or a corresponding fumerate.
Patent JP-3131535-B2 (JP)
IPC: H04W64/00
Filed: 1993-12-20
Granted: 2001-02-05
Abstract: PURPOSE:To devise the system employing the exchange such that the exchange accommodates plural base stations, a general public cordless slave set is connected and extension connection is attained for an in-premises cordless slave set used in a premises. CONSTITUTION:The system employing the exchange is provided with a master set 13 connecting to a public network 11 via a station exchange 12 and having a digital electronic exchange function, plural base stations 14 connecting to the master set 13 via a digital line, public cordless slave sets 15 and in-premises cordless slave sets 16 connecting to each base station 14 through a radio channel. The master set 13 is provided with a position registration means 13a for the public cordless slave sets 15 and in-premises cordless slave sets 16 and a means 13b informing the position registration of the public cordless slave sets 15 to the public network 11. The master set 13 connects the public cordless slave sets 15 to the public network 11 and applies extension connection to the in-premises cordless slave sets 16.
Patent JP-3385224-B2 (JP)
IPC: F25D15/00
Filed: 1998-12-25
Granted: 2003-03-10
Abstract: PROBLEM TO BE SOLVED: To improve a cooling capability and to reduce cost by cooling a large space in a storage cabinet to a predetermined temperature, and easily maintaining in a narrow temperature range zone of an icing point of a storage material. SOLUTION: An antifreeze solution in a cool thermal storage tank 31 is iced and fed upward. The solution (a) at a bottom of a cooler casing 21 is injected from a jet nozzle 33 in an upper part to prevent adherence of iced fine particles of the solution to each other in the tank 31. A low temperature antifreeze solution (a') is outputted from an outlet 35, supplied to the bottom of the casing 21, the solution (a') is circulated and injected from the nozzle 25, the air is brought upward into contact with the solution (a') as a counterflow to obtain a cold air.
Patent JP-H0455172-B2 (JP)
IPC: A61P35/00
Filed: 1983-03-07
Abstract: PCT No. PCT/FR83/00044 Sec. 371 Date Oct. 21, 1983 Sec. 102(e) Date Oct. 21, 1983 PCT Filed Mar. 7, 1983 PCT Pub. No. WO83/03055 PCT Pub. Date Sep. 15, 1983.The present invention relates to medicaments comprising, in association, at least one immunotoxin and chloroquin.
Patent JP-3741726-B2 (JP)
IPC: H02J5/00
Filed: 1995-05-26
Granted: 2006-02-01
Abstract: A device (10) for placement between adjacent bone masses to promote bone growth therebetween, said device comprising: 
an implant (30) having opposed first and second portions for placement between and in contact with the adjacent bone masses, each of said first and second portions have at least one opening (42) adapted to permit bone growth from adjacent bone mass to adjacent bone mass though said implant; and 
a power supply (60) for energizing said implant to promote bone growth, said power supply being adapted to energize said implant from a point external to a patient's body.
Patent JP-2641986-B2 (JP)
IPC: G01N1/14
Filed: 1989-11-17
Granted: 1997-08-20
Abstract: The sample liquids analysis system includes a probe which is automatically operable to successively aspirate sample liquids and reagent and/or other sample liquids processing liquids and to dispense the same in turn into sample liquids analysis apparatus for automatic, successive sample liquids analyses. Isolation liquid supply apparatus are operatively associated with the sample liquids aspirating the dispensing probe and operate to introduce an isolation liquid which is immiscible with the sample liquids and which selectively wets the probe to the substantial exclusion of the sample liquids, to the probe to, in combination with operatively associated rinse liquid supply apparatus which operate to fill the probe with a rinse liquid between successive sample liquids aspirations, reduce sample liquids carryover to ultra low levels. The sample liquids aspirating and dispensing probe are operated by the rinse liquid supply apparatus; and comprise a probe body member, and an active probe component operatively connected thereto by a readily disconnectable connector, thus making possible the ready and convenient replacement of the active probe component without adverse effect upon the essential configuration and/or operational characteristics of the rinse liquid supply apparatus, and thereby upon the overall performance of the sample liquids analysis system. The configuration of the probe operates to reduce sample liquids flow velocity in the active probe component, thereby further reducing sample liquids carryover.
Patent JP-3023993-B2 (JP)
IPC: C07D521/00
Filed: 1996-06-19
Granted: 2000-03-21
Abstract: PCT No. PCT/US96/09249 Sec. 371 Date Dec. 22, 1997 Sec. 102(e) Date Dec. 22, 1997 PCT Filed Jun. 19, 1996 PCT Pub. No. WO97/00849 PCT Pub. Date Jan. 9, 1997Vinyl sulfides bearing protected arlyoxy substituents and a process for their preparation are provided. In the process a vinyl sulfide is formed by coupling a ketone compound and a thioester compound with a low valent titanium reagent to form both carbon-carbon bonds in the same step. The vinyl sulfide compounds are useful as intermediates which are convertible into triggerable sulfur-substituted dioxetanes by addition of oxygen to the double bond. The sulfur-substituted dioxetanes additionally are useful for producing chemiluminescence or for further conversion into triggerable alkoxy, alkenyloxy, alkynloxy, aryloxy, aralkyloxy, or acyloxy-substituted dioxetanes. Triggerable dioxetanes are useful for producing chemiluminescence and in detecting activating agents in assays such as immunoassays and nucleic acid hybridization assays.
Patent JP-2828642-B2 (JP)
IPC: C07H19/10
Filed: 1988-06-24
Granted: 1998-11-25
Abstract: A nucleoside derivative of formula (1), characterized in that: Y is H or OH or a protected hydroxy group; X is H, a phosphonate group or a phosphoramidite group of formula (II), where R1 and R2 are the same or different, and are selected from alkyl and substituted alkyl, which may be branched or unbranched; and Q is a phosphate protecting group; Z is H, a phosphate or triphosphate group or hydroxy protecting group; X' is a C1-15 alkyl group which may be branched or unbranched; R is an amino protecting group or a fluorophore, or other non-radioactive detectable marker; or the group Y'NHA, where Y' is an alkyl (C1-40) carbonyl group which may be branched or unbranched, and A is an amino protecting group or a fluorophore or other non-radioactive detectable marker. Methods for the synthesis and sequencing of polynucleotides utilizing compounds of formula (I).
Patent JP-3350061-B2 (JP)
IPC: A61K31/52
Filed: 1998-07-01
Granted: 2002-11-25
Abstract: PCT No. PCT/EP98/04176 Sec. 371 Date Jan. 27, 2000 Sec. 102(e) Date Jan. 27, 2000 PCT Filed Jul. 1, 1998 PCT Pub. No. WO99/01135 PCT Pub. Date Jan. 14, 1999The present invention provides an aqueous pharmaceutical composition comprising 5 to 200 mg/ml of eletriptan hemisulfate and from 0.5 to 2.0% weight/volume of caffeine.
Patent JP-3010500-B2 (JP)
IPC: A61K51/12
Filed: 1990-04-13
Granted: 2000-02-21
Abstract: Liposomes of a size of less than 200 nanometers target ischemic myocardial tissue and preferentially deliver active agents to infarcted areas in the absence of antibodies bound to the liposomes to effect the delivery.
Patent JP-H0673763-B2 (JP)
IPC: F16L27/087
Filed: 1990-04-18
Abstract: The present invention is a tool assembly comprising a tool block and a tool holder capable of delivering chip-breaking fluid to the tool holder without a fixed attachment to the tool holder. The tool block is formed with a tool shank cavity having a tool support surface. The tool holder includes a shank insertable into the tool shank cavity of the tool block. A fluid delivery passage is formed in the tool block which terminate in an outlet opening. A primary fluid passage is formed in the tool holder and terminates in a discharge orifice positioned to direct a fluid jet at the chip being removed from the workpiece. A fluid path provides a path for the flow of chip-breaking fluid from the outlet of the delivery passage to the inlet of the primary fluid passage throughout the entire range of relative movement between the tool block and holder. In the preferred embodiment, the fluid path is a shallow recess formed in either the tool shank or tool block which forms an enclosed fluid cavity when the tool holder is mounted to the tool block.
Patent JP-3566285-B2 (JP)
IPC: A61M16/00
Filed: 1992-11-13
Granted: 2004-09-15
Abstract: The present invention relates to systems and methods for automatically and continuously regulating the level of nasal pressure to an optimal value during OSA treatment. OSA therapy is implemented by a device which automatically re-evaluates an applied pressure and continually searches for a minimum pressure required to adequately distend a patient's pharyngeal airway. For example, this optimal level varies with body position and stage of sleep throughout the night. In addition, this level varies depending upon the patient's body weight and whether or not alcohol or sleeping medicine has been ingested.
Patent JP-3288382-B2 (JP)
IPC: C07C209/84
Filed: 1993-12-17
Granted: 2002-06-04
Abstract: Disclosed is a method for decolorizing alkylated diarylamines, which have been made using aluminum chloride catalyst, by mixing and optionally heating the colored diarylamine with clay, then separating the decolorized diarylamine from the clay. Alternatively, the alkylated diarylamines, which have been made using aluminum chloride catalyst, may be decolorized by passing the diarylamines through a filter medium comprising clay.
Patent JP-3693672-B2 (JP)
IPC: A01N61/00
Filed: 1994-12-15
Granted: 2005-09-07
Abstract: PCT No. PCT/EP94/04174 Sec. 371 Date Aug. 5, 1996 Sec. 102(e) Date Aug. 5, 1996 PCT Filed Dec. 15, 1994 PCT Pub. No. WO95/16913 PCT Pub. Date Jun. 22, 1995A method for identifying substances with a potential herbicidal and growth-regulating action by means of plant transporter proteins (transporters), the use thereof and substances identifiable by the method and having a herbicidal and growth-regulating action are described.
Patent JP-4297514-B2 (JP)
IPC: B29C48/305
Filed: 1994-12-19
Granted: 2009-07-15
Abstract: Extrusion films and coatings are prepared by applying a polyhydroxyalkanoate (PHA) to a surface which is in the range from 20  DEG C above to 20  DEG C below the optimum crystallisation temperature of the PHA. A PHA of high melt flow index is preferred.
Patent JP-3607704-B2 (JP)
IPC: C07K14/705
Filed: 1997-10-13
Granted: 2005-01-05
Abstract: To provide a nucleic acid encoding a receptor protein kinase, wherein the nucleic acid has tandem duplication in a nucleotide sequence of a juxtamembrane and is useful for diagnosis of leukemia; a polypeptide encoded by the nucleic acid; an antibody capable of specifically binding to a region encoded by the nucleic acid having tandem duplication occurring in a nucleotide sequence of a juxtamembrane; a nucleic acid capable of specifically binding to the nucleic acid having tandem duplication occurring in a nucleotide sequence of a juxtamembrane; a method for detection of the nucleic acid encoding a receptor protein kinase; and a kit therefor. A nucleic acid encoding a receptor protein kinase, wherein the nucleic acid has tandem duplication in a nucleotide sequence of a juxtamembrane; a polypeptide encoded by the nucleic acid; an antibody capable of specifically binding to the portion of the polypeptide; a nucleic acid capable of specifically binding to the nucleic acid; a method for detection of the nucleic acid; and a kit for detection.
Patent JP-3492691-B2 (JP)
IPC: B03B5/36
Filed: 1994-03-17
Granted: 2004-02-03
Abstract: PCT No. PCT/DE94/00313 Sec. 371 Date Aug. 9, 1995 Sec. 102(e) Date Aug. 9, 1995 PCT Filed Mar. 17, 1994 PCT Pub. No. WO94/21382 PCT Pub. Date Sep. 29, 1994A process for separating mixtures of solids of different density, uses a separating liquid and a device for implementing the process. The process is especially suitable for the analysis and technical preparation of waste plastics, glass and electrical scrap. In the process, a reduced mixture of solids with a particle size of 0.1 to 80 mm are brought successively into contact with solutions of separating liquids of differing density in steps of 0.005 to 0.1 g/cm3 within a selected range from that between 0.8 and 2.9 g/cm3 and the floating or sinking solid components are separated after each step. The separating liquid in the density range between 1 and 2.9 is preferably an aqueous solution of an alkali metal salt or an alkaline earth metal salt of metatungstate with a concentration in the range 1 to 80 weight % and an oxidant selected from the chromate, dichromate, permanganate, nitrate, peracid and perester group with a concentration of 0.05 to 0.5 weight %.
Patent JP-3513764-B2 (JP)
IPC: A61K31/517
Filed: 1998-06-15
Granted: 2004-03-31
Abstract: A composition for the topical transdermal administration to the penis is based on prostaglandin E1. The composition is non-irritating and effective for relieving erectile impotence or other penile erectile dysfunction. A penetration enhancing effective amount of a dioxolane, dioxane, or acetal skin penetration enhancing compound in a pharmaceutically acceptable aqueous alcoholic carrier is used to facilitate the penetration of the prostaglandin E1 active ingredient through the skin. Phentolamine or prazosin may be used in combination with prostaglandin E1.
Patent JP-4827274-B2 (JP)
IPC: G10L15/06
Filed: 1998-12-14
Granted: 2011-11-30
Abstract: In a product including a speech recognition device for controlling at least one processing unit while using a command lexicon containing commands which depends as regards its contents on an activated operating state of a processing unit and which speech recognition device includes a command lexicon memory in which commands of the command lexicon can be stored in the form of command information and identification information assigned to the latter, and which speech recognition device includes speech recognition means for detecting command information-contained in speech information representing a spoken command-and delivers command information to the at least one processing unit, generating means are provided which are arranged for generating-after an operating state of a processing unit has been activated-which may be effected with the aid of command information detected in a spoken command-a command lexicon assigned to only this one activated operating state and for storing this command lexicon in the command lexicon memory.
Patent ES-2197000-B2 (ES)
Title: Metodo de ajuste de una caracteristica en un procedimiento de fabricacion de productos.
Inventor: ITO YOSHIHARU
IPC: G06Q50/00
Filed: 2002-03-25
Granted: 2004-11-16
Abstract: Método de ajuste de una característica en un procedimiento de fabricación de productos. En una base de datos de control del procedimiento, las características intermedias, la condición de procesamiento para controlar una característica y una característica final en un procedimiento de fabricación de productos son almacenados como conjunto de datos para cada lote de productos. En "Procedimiento 1" es preparado un conjunto de datos para cada lote de productos. A continuación en "Procedimiento 2" es realizado un procedimiento por conglomerados sobre cada conjunto de datos obtenidos en "Procedimiento 1". En "Procedimiento 3", usando el conjunto de datos obtenidos en "Procedimiento 2", son introducidas las características intermedias y la condición de procesamiento para controlar una característica y es obtenida la característica final, y una relación causal entre la entrada y la salida es cuantificada mediante una red neural para confeccionar un modelo de aprendizaje. En una etapa de aplicacióndel modelo es seleccionada la condición de procesamiento más apropiada para controlar una característica usando el modelo de aprendizaje y las características intermedias en las etapas anteriores.
Patent ES-2381526-B2 (ES)
Title: Máquina encajadora de productos hortofrutículas embolsados.
Inventor: BAENA BORREGO FRANCISCO
IPC: B65B5/06
Filed: 2010-11-02
Granted: 2013-12-18
Abstract: Máquina encajadora de productos hortofrutícolas embolsados.#Prevista para el llenado de cajas (10) receptoras de un determinado número de bolsas con el producto dosificado, cuenta con un sistema de alimentación (2, 2?) que deposita las bolsas sobre un dispensador (3) situado por debajo de las mismas y materializado en una pareja de pseudo-rodillos paralelos, horizontales y lateralmente adyacentes, de perfil angular equilátero, capacitados para establecer una situación de cierre en la que retienen las bolsas de producto que caen desde las cintas transportadoras (2, 2?) del sistema de alimentación, y de pasar seguidamente a una situación de apertura en la que las bolsas caen sobre la caja inferior (10), definiendo un ciclo operativo en cada giro en sentido contrario de 120º por parte de dichos pseudo-rodillos. Se consigue de esta manera una máquina encajadora estructuralmente mucho más simple que los robots convencionales, con la consecuente repercusión económica que ello supone y manteniendo unas óptimas prestaciones tanto desde el punto de vista funcional como productivo.
Patent ES-2367734-B2 (ES)
Inventor: SANTOYO GONZALEZ FRANCISCO
IPC: B01D11/00
Filed: 2011-07-11
Granted: 2012-03-16
Abstract: The present invention relates to a method for extraction of maslinic and oleanolic acids and hydroxytyrosol from olive-dressing solutions, which comprises the following steps: a) flocculation of the olive-dressing solutions to obtain a flocculant and water; b) solid/liquid extraction and drying of the flocculant obtained in step a); c) extraction of the flocculant from step b); purification of the extract obtained after step c); and e) liquid/liquid extraction of the water obtained after steps a) and b).
Patent AU-2001236794-B2 (AU)
Title: Method for classifying and treating physiologic brain imbalances using quantitative EEG
Inventor: SUFFIN STEPHEN
IPC: A61B5/374
Filed: 2001-02-09
Granted: 2004-09-09
Abstract: The present invention relates to a method for determining medication efficacy, comprising: 
a) providing; 
i) a patient having a physiologic brain imbalance, wherein said imbalance is identified using a first electroencephalography recording, and 
ii) a medication; and,  
b) converting said first electroencephalography recording to at least one first multivariate outcome measurement wherein said first outcome measurement comprises a plurality of first univariate Z scores, wherein said first multivariate outcome measurement is derived from a frequency band selected from the group consisting of delta, theta, alpha, and beta; 
c) administering said medication to said patient; 
d) obtaining a second electroencephalography recording from said patient and converting said second electroencephalography recording to at least one second multivariable outcome measurement wherein said second outcome measurement comprises a plurality of second univariate Z scores, wherein said second multivariate outcome measurement is derived from a frequency band selected from the group consisting of delta, theta, alpha, and beta; and 
e) comparing said first multivariate outcome measurement with said second multivariate outcome measurement wherein a differential change between said first and second measurement determines said medication efficacy.
Patent AU-2001243431-B2 (AU)
Title: Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
Inventor: WALLER DONALD PAUL
IPC: A61K9/06
Filed: 2001-03-06
Granted: 2006-05-25
Abstract: Antimicrobial and contraceptive compositions and methods which prevent and/or reduce the risk of transmission of sexually transmitted diseases through sexual activity as well as prevent and/or reduce the risk of pregnancy are provided. The compositions contain (1) a matrix-forming agent, (2) a bio-adhesive agent, (3) a buffering agent, (4) optionally a humectant, (5) optionally a preservative, and (6) water; wherein the composition is suitable for application within the vagina; wherein the compositions forms a semisolid matrix on contact with ejaculate (thereby trapping ejaculated microbes and spermatozoa); wherein the composition causes hardening of cervical mucus (thereby decreasing the probability of sperm entry); wherein the composition forms a bio-adhesive layer over vaginal surfaces (thereby preventing or reducing the risk of contact of STD-causing microbes with the vaginal surfaces); wherein the composition maintains an acidic vaginal pH of less than about 5 in the presence of semen ejaculated from the male; and wherein the composition does not significantly impair the natural microbiological balance within the vagina. The antimicrobial and contraceptive compositions may also contain additional antimicrobial and/or contraceptive agents (e.g., nonoxynol-9, octoxynol-9, benzalkonium chloride, phosphorylated hesperidins, sulfonated hesperidins, polystyrene sulfonates, substituted benzenesulfonic acid formaldehyde co-polymers, H2SO4-modified mandelic acids, povidone iodine, itraconazole, ketoconazole, metronidazole, clotrimazole, fluconazole, teraconazole, miconazole, tinidazole, iconazole, chloramphenicol, nystatin, cyclopiroxolamine, and the like).